MoonLake Immunotherapeutics Statistics
NASDAQ: MLTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
10.77-0.18 (-1.64%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
MoonLake Immunotherapeutics by the numbers
MoonLake Immunotherapeutics has a market capitalization of $916.6 million based on 85.11M shares outstanding. With trailing EPS of $-3.77, MoonLake Immunotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 27.3% below its 50-day average and 35.6% below its 200-day average.
Average daily trading volume is 1.44M shares, or about $15.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MLTX valuation vs. peer median
| Metric | MLTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $916.60M | $900.62M | +2% |
| Avg. volume | 1.44M | 582.07K | +147% |
Peer median across 8 companies: ANRO, KURA, ANL, SPTX, RIGL, CYRX, ALMS, JBIO.
Valuation
- Market cap
- $916.60M
- EPS (TTM)
- $-3.77
- Shares outstanding
- 85.11M
Price and trading
- Previous close
- 10.95
- Open
- 10.80
- Day range
- 10.71 – 11.29
- 52-week range
- 8.80 – 23.29
- 52-week change
- +16.06%
- Beta
- —
- Volume
- 1.40M
- Average volume
- 1.44M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 916.60M
- Forward Pe
- -3.24
- Eps
- -3.77
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 23.29
- Week52 Low
- 8.80
- Avg Volume
- 1.44M
- Shares Outstanding
- 85.11M
- Ma50
- 14.81
- Ma200
- 16.74
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -53.76%
- Pct From52w Low
- 22.39%